ABOUT PHARMA EXCIPIENTS

“The present problem has uncovered some structural weaknesses from the EU’s medicines provide chain plus a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advisable that offer chain issues be dealt with in an EU pharmaceutical strategy envisioned to be introduced by the